Defeating pathogen drug resistance: guidance from evolutionary theory

Area of Science:

• Evolutionary biology
• Medicine
• Public health

Background:

• Pathogen drug resistance poses a significant challenge in medicine and public health.
• Understanding evolutionary responses to drug pressure is crucial for effective treatment strategies.

Purpose of the Study:

• To explore two classes of pathogen traits based on their evolutionary response to drugs.
• To propose a shift in drug and vaccine development towards targeting group-beneficial traits.

Main Methods:

• Analysis of natural selection theory applied to pathogen evolution.
• Categorization of pathogen traits based on individual versus group benefits.
• Discussion of implications for drug and vaccine development.

Main Results:

• Traits benefiting individual pathogens elicit a strong evolutionary response, leading to rapid drug resistance.
• Traits benefiting pathogen groups elicit a weaker evolutionary response, resulting in slower drug resistance.
• Targeting group-beneficial traits presents an advantageous strategy for combating drug resistance.

Conclusions:

• Drug development should prioritize targeting pathogen traits that benefit the group.
• This approach can mitigate the emergence of drug resistance.
• Focusing on group-beneficial traits offers a novel strategy for future drug and vaccine design.